{"content":[{"text":"FLETCHER SPAGHT, INC. \n Highlights \n Q4, 2020","bbox":{"left":0.327333,"top":0.017296,"width":0.34532700000000005,"height":0.11413699999999999}},{"text":"Home and Community Based Medicaid Services \n Developed a growth strategy for a private equity owned provider of services to support people \n with intellectual and/or developmental disabilities (I/DD); included a prioritization of states for \n commercial Medicaid home services to inform a broader US expansion strategy and in-depth \n market opportunity assessments for home-based Medicaid services in selected states; identified \n potential provider acquisition targets for the client.","bbox":{"left":0.06,"top":0.161003,"width":0.8774850000000001,"height":0.10991599999999996}},{"text":"Virtual Clinical Trials \n Assisted investor by analyzing the virtual clinical trial market; researched pharmaceutical \n company needs; studied the sector’s view of the gaps in the current virtual trial offerings; sized \n the market and created a market model of the sector; developed alternative growth scenarios with \n range of potential returns to benefit the client.","bbox":{"left":0.06,"top":0.293045,"width":0.8770519999999999,"height":0.09454099999999999}},{"text":"Women’s Health \n Performed a due diligence on a novel technology for treating fibroids; FSI researched the US and \n European markets including extensive one-on-one interviews to define clinician interest and \n potential adoption across community and academic settings; probed on features that impacted \n adoption versus those features that were of interest but did not influence the purchase decision.","bbox":{"left":0.06,"top":0.409739,"width":0.8772960000000001,"height":0.09454099999999993}},{"text":"Downstream Bioprocessing \n Created a detailed analysis of the biopharma chromatography resin market to understand which \n types of resins are used in each purification step; conducted extensive outreach within the \n biopharma sector to understand selection of resin type and how the space may evolve as newer \n classes of biologics with different purification challenges than traditional monoclonal antibodies \n gain share.","bbox":{"left":0.06,"top":0.526406,"width":0.8771740000000001,"height":0.10974899999999987}},{"text":"Investment Fund Operating Plan \n Developed a business and operating plan for a proposed internal investment fund at a leading \n academic medical center; the fund is aimed at supporting promising pre-clinical therapeutics, \n accelerating medical research and commercial application of inventions and technologies \n developed within the health system; worked with the internal team to define strategy and vision \n for the fund; engaged others within the organization to solicit comments and feedback; reviewed \n and incorporated findings from similar hospital / academic investment funds; plan was \n instrumental in securing approval and financing for the fund.","bbox":{"left":0.06,"top":0.658448,"width":0.8601110000000001,"height":0.14020699999999986}},{"text":"Page 2 of 4 \n www.fletcherspaght.com","bbox":{"left":0.073467,"top":0.92945,"width":0.222333,"height":0.04223500000000002}},{"text":"Growth","bbox":{"left":0.740444,"top":0.9363,"width":0.069222,"height":0.021599999999999953}},{"text":"Focused","bbox":{"left":0.865241,"top":0.9563,"width":0.07773299999999994,"height":0.021599999999999953}}],"images_bbox":[{"left":0.012444,"top":0.888167,"width":0.973555,"height":0.01166}],"images_bbox_not_text_overlap":[{"left":0.012444,"top":0.888167,"width":0.973555,"height":0.01166}]}